Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Clostridium difficile is the principal cause of antibiotic-associated diarrhea. Major metabolic requirements for colonization and expansion of C. difficile after microbiota disturbance have not been fully determined. In this study, we show that glutamate utilization is important for C. difficile to establish itself in the animal gut. When the gluD gene, which codes for glutamate dehydrogenase (GDH), was disrupted, the mutant C. difficile was unable to colonize and cause disease in a hamster model. Further, from the complementation experiment it appears that extracellular GDH may be playing a role in promoting C. difficile colonization and disease progression. Quantification of free amino acids in the hamster gut during C. difficile infection showed that glutamate is among preferred amino acids utilized by C. difficile during its expansion. This study provides evidence of the importance of glutamate metabolism for C. difficile pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974
Research works printed but not linked: 62
- JG Bartlett, 2006, Narrative review: the new epidemic of Clostridium difficile-associated enteric disease, Annals of internal medicine, 145, 758, 10.7326/0003-4819-145-10-200611210-00008 · DOI · Paper page
- E Dolgin, 2011, 'Game changer' antibiotic and others in works for superbug, Nature medicine, 17, 10, 10.1038/nm0111-10 · doi:10.1038/nm0111-10
- T Monaghan, 2008, Recent advances in Clostridium difficile-associated disease, Gut, 57, 850
- JG Bartlett, 1978, Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis, Gastroenterology, 75, 778, 10.1016/0016-5085(78)90457-2 · DOI · Paper page
- JL Giel, 2010, Metabolism of bile salts in mice influences spore germination in Clostridium difficile, PloS one, 5, e8740, 10.1371/journal.pone.0008740 · DOI · Paper page
- V Braun, 1996, Definition of the single integration site of the pathogenicity locus in Clostridium difficile, Gene, 181, 29, 10.1016/S0378-1119(96)00398-8 · DOI · Paper page
- DE Voth, 2005, Clostridium difficile toxins: mechanism of action and role in disease, Clinical microbiology reviews, 18, 247, 10.1128/CMR.18.2.247-263.2005 · DOI · Paper page
- A Antunes, 2012, Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile, Nucleic acids research, 40, 10701, 10.1093/nar/gks864 · DOI · Paper page
- L Bouillaut, 2015, Integration of metabolism and virulence in Clostridium difficile, Research in microbiology, 166, 375, 10.1016/j.resmic.2014.10.002 · DOI · Paper page
- SS Dineen, 2010, Integration of metabolism and virulence by Clostridium difficile CodY, Journal of bacteriology, 192, 5350, 10.1128/JB.00341-10 · DOI · Paper page
- SS Dineen, 2007, Repression of Clostridium difficile toxin gene expression by CodY, Molecular microbiology, 66, 206, 10.1111/j.1365-2958.2007.05906.x · DOI · Paper page
- S Karlsson, 1999, Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids, Microbiology, 145, 1683, 10.1099/13500872-145-7-1683 · DOI
- S Karlsson, 2000, Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile, Infection and immunity, 68, 5881, 10.1128/IAI.68.10.5881-5888.2000 · DOI · Paper page
- T Maegawa, 2002, Linkage between toxin production and purine biosynthesis in Clostridium difficile, Journal of medical microbiology, 51, 34, 10.1099/0022-1317-51-1-34 · doi:10.1099/0022-1317-51-1-34
- KL Nawrocki, 2016, CodY-dependent Regulation of Sporulation in Clostridium difficile, Journal of bacteriology
- L Bouillaut, 2013, Proline-dependent regulation of Clostridium difficile Stickland metabolism, Journal of bacteriology, 195, 844, 10.1128/JB.01492-12 · DOI · Paper page
- T Karasawa, 1995, A defined growth medium for Clostridium difficile, Microbiology, 141, 371, 10.1099/13500872-141-2-371 · DOI · Paper page
- HA Barker, 1981, Amino acid degradation by anaerobic bacteria, Annual review of biochemistry, 50, 23, 10.1146/annurev.bi.50.070181.000323 · DOI · Paper page
- MJ Merrick, 1995, Nitrogen control in bacteria, Microbiological reviews, 59, 604, 10.1128/MMBR.59.4.604-622.1995 · doi:10.1128/mmbr.59.4.604-622.1995 · Paper page
- BM Anderson, 1993, Purification and characterization of Clostridium difficile glutamate dehydrogenase, Archives of biochemistry and biophysics, 300, 483, 10.1006/abbi.1993.1065 · doi:10.1006/abbi.1993.1065
- KC Carroll, 2011, Tests for the diagnosis of Clostridium difficile infection: the next generation, Anaerobe, 17, 170, 10.1016/j.anaerobe.2011.01.002 · DOI
- N Shetty, 2011, The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis, The Journal of hospital infection, 77, 1, 10.1016/j.jhin.2010.07.024 · DOI
- BP Girinathan, 2014, Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2, Microbiology, 160, 47, 10.1099/mic.0.071365-0 · DOI
- JR O'Connor, 2006, Construction and analysis of chromosomal Clostridium difficile mutants, Molecular microbiology, 61, 1335, 10.1111/j.1365-2958.2006.05315.x · DOI · Paper page
- AR Sirigi Reddy, 2013, Identification and characterization of Clostridium sordellii toxin gene regulator, Journal of bacteriology, 195, 4246, 10.1128/JB.00711-13 · DOI
- JJ Varga, 2006, Type IV pili-dependent gliding motility in the Gram-positive pathogen Clostridium perfringens and other Clostridia, Molecular microbiology, 62, 680, 10.1111/j.1365-2958.2006.05414.x · DOI · Paper page
- R Govind, 2015, Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion, Journal of bacteriology, 197, 2600, 10.1128/JB.00224-15 · DOI
- FE Young, 1961, Physiological and genetic factors affecting transformation of Bacillus subtilis, Journal of bacteriology, 81, 823, 10.1128/JB.81.5.823-829.1961 · DOI
- F Teng, 1998, Conjugal transfer of plasmid DNA from Escherichia coli to enterococci: a method to make insertion mutations, Plasmid, 39, 182, 10.1006/plas.1998.1336 · DOI
- O Okwumabua, 2001, Cloning and characterization of the gene encoding the glutamate dehydrogenase of Streptococcus suis serotype 2, Clinical and diagnostic laboratory immunology, 8, 251, 10.1128/CDLI.8.2.251-257.2001 · doi:10.1128/cdli.8.2.251-257.2001
- TW Chang, 1978, Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients, Infection and immunity, 20, 526, 10.1128/IAI.20.2.526-529.1978 · DOI
- SP Sambol, 2001, Infection of hamsters with epidemiologically important strains of Clostridium difficile, The Journal of infectious diseases, 183, 1760, 10.1086/320736 · DOI · Paper page
- HW Koon, 2014, Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum, Antimicrobial agents and chemotherapy, 58, 4642, 10.1128/AAC.02783-14 · DOI
- C Pothoulakis, 1994, CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin, Proceedings of the National Academy of Sciences of the United States of America, 91, 947, 10.1073/pnas.91.3.947 · DOI · Paper page
- KE Fujimura, 2010, Role of the gut microbiota in defining human health, Expert review of anti-infective therapy, 8, 435, 10.1586/eri.10.14 · DOI · Paper page
- RA Britton, 2014, Role of the intestinal microbiota in resistance to colonization by Clostridium difficile, Gastroenterology, 146, 1547, 10.1053/j.gastro.2014.01.059 · DOI · Paper page
- C Feehily, 2013, Role of glutamate metabolism in bacterial responses towards acid and other stresses, Journal of applied microbiology, 114, 11, 10.1111/j.1365-2672.2012.05434.x · DOI · Paper page
- RM Wohlheuter, 1973, The Enzymes of Glutamine Metabolism., The Enzymes of Glutamine Metabolism., 45
- GA Somerville, 2009, At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci, Microbiology and molecular biology reviews: MMBR, 73, 233, 10.1128/MMBR.00005-09 · DOI · Paper page
- C Schoen, 2014, Metabolism and virulence in Neisseria meningitidis, Frontiers in cellular and infection microbiology, 4, 114, 10.3389/fcimb.2014.00114 · DOI
- K Shibayama, 2007, Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism, Molecular microbiology, 64, 396, 10.1111/j.1365-2958.2007.05661.x · DOI
- SA Kuehne, 2014, Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain, The Journal of infectious diseases, 209, 83, 10.1093/infdis/jit426 · DOI · Paper page
- GP Carter, 2015, Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections, mBio, 6, e00551, 10.1128/mBio.00551-15 · DOI · Paper page
- KA Fimlaid, 2015, Identification of a Novel Lipoprotein Regulator of Clostridium difficile Spore Germination, PLoS pathogens, 11, e1005239, 10.1371/journal.ppat.1005239 · DOI
- X Wu, 2014, The Clostridium difficile proline racemase is not essential for early logarithmic growth and infection, Canadian journal of microbiology, 60, 251, 10.1139/cjm-2013-0903 · DOI
- TD Ho, 2014, Clostridium difficile extracytoplasmic function sigma factor sigmaV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection, Infection and immunity, 82, 2345, 10.1128/IAI.01483-13 · DOI · Paper page
- D Lyras, 2009, Toxin B is essential for virulence of Clostridium difficile, Nature, 458, 1176, 10.1038/nature07822 · DOI · Paper page
- RW McKee, 2013, The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD, Journal of bacteriology, 195, 5174, 10.1128/JB.00501-13 · DOI
- AM Seekatz, 2014, Recovery of the gut microbiome following fecal microbiota transplantation, mBio, 5, e00893, 10.1128/mBio.00893-14 · DOI · Paper page
- M Neumann-Schaal, 2015, Time-resolved amino acid uptake of Clostridium difficile 630Deltaerm and concomitant fermentation product and toxin formation, BMC microbiology, 15, 281, 10.1186/s12866-015-0614-2 · DOI
- A Pompella, 2003, The changing faces of glutathione, a cellular protagonist, Biochemical pharmacology, 66, 1499, 10.1016/S0006-2952(03)00504-5 · DOI · Paper page
- H Xue, 2011, New role of glutamate as an immunoregulator via glutamate receptors and transporters, Frontiers in bioscience, 3, 1007, 10.2741/s205 · doi:10.2741/s205
- S Bruzzone, 2001, A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts, The Journal of biological chemistry, 276, 48300, 10.1074/jbc.M107308200 · DOI · Paper page
- M Romanello, 2001, Extracellular NAD(+) induces calcium signaling and apoptosis in human osteoblastic cells, Biochemical and biophysical research communications, 285, 1226, 10.1006/bbrc.2001.5325 · DOI
- C Stringari, 2012, Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH, Scientific reports, 2, 568, 10.1038/srep00568 · DOI · Paper page
- SJ Hwang, 2011, beta-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons, Gastroenterology, 140, 608, 10.1053/j.gastro.2010.09.039 · DOI
- X Han, 2003, NAD+ ameliorates inflammation-induced epithelial barrier dysfunction in cultured enterocytes and mouse ileal mucosa, The Journal of pharmacology and experimental therapeutics, 307, 443, 10.1124/jpet.103.056556 · DOI
- A Heinrich, 2006, Interaction of the membrane-bound GlnK-AmtB complex with the master regulator of nitrogen metabolism TnrA in Bacillus subtilis, The Journal of biological chemistry, 281, 34909, 10.1074/jbc.M607582200 · DOI
- MA Strickler, 2009, Functional characterization of a Na(+)-coupled dicarboxylate transporter from Bacillus licheniformis, Biochimica et biophysica acta, 1788, 2489, 10.1016/j.bbamem.2009.10.008 · doi:10.1016/j.bbamem.2009.10.008
- A Gupta, 2014, Community-acquired Clostridium difficile infection: an increasing public health threat, Infection and drug resistance, 7, 63
- C Rangan, 2009, Food additives and sensitivities, Disease-a-month: DM, 55, 292, 10.1016/j.disamonth.2009.01.004 · DOI
- DM Lyerly, 1991, Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase, Journal of clinical microbiology, 29, 2639, 10.1128/JCM.29.11.2639-2642.1991 · DOI · Paper page
Cited by
Potential and active functions in the gut microbiota of a healthy human cohort
Tanca, A., Abbondio, M., Palomba, A., Fraumene, C., Manghina, V., Cucca, F., Fiorillo, E., & Uzzau, S. (2017) · Microbiome · doi:10.1186/s40168-017-0293-3 · Cited by 172
The Role of the Microbiota–Gut–Brain Axis and Antibiotics in ALS and Neurodegenerative Diseases
Obrenovich, M., Jaworski, H., Tadimalla, T., Mistry, A., Sykes, L., Perry, G., & Bonomo, R. (2020) · Microorganisms · doi:10.3390/microorganisms8050784 · Cited by 62
López-Alonso, B., Hernáez, A., Sarnago, H., Naval, A., Güemes, A., Junquera, C., Burdío, J. M., Castiella, T., Monleón, E., Gracia-Llanes, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39433-6 · Cited by 48
Metadata
- Authors
- Girinathan, B. P., Braun, S., Sirigireddy, A. R., Lopez, J. E., & Govind, R.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-07-28
- Volume
- 11
- Issue
- 7
- Pages
- e0160107
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2501071995
- Cited by
- 33
- References
- 1
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Update notices
- correction (2016-10-21)
- Open access
- gold
- Funders
- National Institute of Allergy and Infectious Diseases (US) (R15AI122173-01)
- National Institute of General Medical Sciences (P20GM103418, P30496GM103326)
- National Center for Research Resources (P20RR016475)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.